55 filings
8-K
STOK
Stoke Therapeutics Inc
6 May 24
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
STOK
Stoke Therapeutics Inc
29 Apr 24
Departure of Directors or Certain Officers
4:05pm
8-K
STOK
Stoke Therapeutics Inc
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
8-K
STOK
Stoke Therapeutics Inc
25 Mar 24
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
4:07pm
8-K
STOK
Stoke Therapeutics Inc
25 Mar 24
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:03pm
8-K
xj50s8fzfo90
8 Jan 24
Regulation FD Disclosure
8:09am
8-K
6qmk5 zibn
14 Dec 23
Entry into a Material Definitive Agreement
4:05pm
8-K
i2tvue5r4z0ztlo7rc
1 Dec 23
Regulation FD Disclosure
9:04am
8-K
c56e4x0ervz9qjlwo86
7 Nov 23
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:05am
8-K
sn1xoj w9vvx1fnhhf2
26 Oct 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
k8ld9vxhe
20 Sep 23
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
4:37pm
8-K
vk4ru10
7 Aug 23
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:05am
8-K
dx89ow 34i84mmw282hc
25 Jul 23
Regulation FD Disclosure
7:05am
8-K
2mjxrhkxqta560
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
upwc537nio st7o6
4 May 23
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
42dvz 3cjgq3tu
15 Mar 23
Regulation FD Disclosure
7:10am
8-K
pqr8cx0p2jzdzx064n5
6 Mar 23
Stoke Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
7:07am
8-K
n7b mo8wpusgs1zq8
3 Feb 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
j4nms22fw4a zqpriohv
9 Jan 23
Regulation FD Disclosure
8:10am
8-K
fa7deg
2 Dec 22
Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a
9:05am